REVIEW article

Front. Pharmacol.

Sec. Pharmacogenetics and Pharmacogenomics

Volume 16 - 2025 | doi: 10.3389/fphar.2025.1600787

This article is part of the Research TopicCircumventing Antibiotic ResistanceView all articles

Global Variation in Antibiotic Prescribing Guidelines and the implications for decreasing AMR in the future

Provisionally accepted
  • 1Bahauddin Zakariya University, Multan, Punjab, Pakistan
  • 2Laboratory Medicine Clinical Pharmacology, Strathclyde Institute of Pharmacy and Biomedical Sciences, Faculty of Science, University of Strathclyde, Glasgow, United Kingdom
  • 3Sefako Makgatho Health Sciences University, Pretoria, South Africa
  • 4St George’s Hospital, London, United Kingdom
  • 5Hamdard University Islamabad, Islamabad, Islamabad, Pakistan
  • 6National Institute of Health, Islamabad, Pakistan
  • 7Al Rayan Colleges, Medina, Saudi Arabia
  • 8University of Faisalabad, Faisalabad, Punjab, Pakistan
  • 9Umm al-Qura University, Mecca, Saudi Arabia

The final, formatted version of the article will be published soon.

Introduction: Antimicrobial resistance (AMR) has become a global burden for which inappropriate antibiotic prescribing is an important contributing factor. Antibiotic prescribing guidelines have an important role with improving the quality of antibiotic use if they are evidence based and regularly updated. As a result, help to reduce AMR, which is a critical challenge low- and middle-income countries (LMICs). Consequently, the objective of this study was to evaluate local, national and international antibiotic prescribing guidelines currently available, especially among LMICs, as well as previous challenges, now that the WHO AWaRe book is published providing future direction. Methodology: Google scholar and PubMed searches were complemented by searching official country websites to identify antibiotic prescribing guidelines, especially regarding empiric treatment of bacterial infections, for this narrative review. Data was collected regarding the country of origin, its income level, guideline title, year of publication, development methodology, issuing organization, target population, scope and coverage. In addition, any documentation regarding implementation strategies, compliance and monitoring of outcome measures, as well as any patient education or counselling associated with the guidelines to improve their use. Results/ Findings: 181 guidelines were included, with the majority originating from high-income countries 109 (60.2%), followed by lower-middle-income 40 (22.1%), low-income 18 (9.9%), and upper-middle-income 14 (7.7%) countries. The GRADE methodology was utilized in only 20.4% of the sourced guidelines, predominantly among high-income countries. Patient education was often underemphasized, particularly in LMICs. The findings highlighted significant disparities in guideline development, adaptation, and implementation across the different WHO Regions, confirming previous limited standardization and comprehensiveness of guidelines in LMICs. Conclusion: Significant disparities exist in the availability, structure, and methodological rigor of antibiotic prescribing guidelines across countries with different income levels. Advancing the development and implementation of standardized, context-specific guidelines aligned with the WHO AWaRe framework, and supported by equity-focused reforms, can significantly strengthen antimicrobial stewardship and address the public health challenge of AMR.

Keywords: Antibiotic Prescribing Guidelines, antimicrobial resistance, AWaRe classification, guidelines, Grade, LMICs, Patient counselling, WHO Regions

Received: 26 Mar 2025; Accepted: 13 Jun 2025.

Copyright: © 2025 Jamil, Saleem, Godman, Ullah, Hassan, Haseeb, Meyer, Qamar and Almarzoky Abuhussain. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Zikria Saleem, Bahauddin Zakariya University, Multan, 60800, Punjab, Pakistan
Brian Godman, Laboratory Medicine Clinical Pharmacology, Strathclyde Institute of Pharmacy and Biomedical Sciences, Faculty of Science, University of Strathclyde, Glasgow, United Kingdom

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.